$6.010
-0.147 (-2.44%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de ACRS por análisis de gráficos similares
Alphio's ACRS stock price prediction model matches the current Aclaris Therapeutics, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $6.05 (+0.59%). The 1-week path is $6.15 (+2.40%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Aclaris Therapeutics, Inc.?
Aclaris Therapeutics Inc is a good buy right now due to its current price of $6.01, which is significantly below the average analyst price target of $11.75, suggesting a potential upside of approximately 95%. Additionally, the company has a strong cash position of $170.6 million, which is expected to fund operations through the end of 2028, providing a buffer against operational challenges. However, the main risk is the company's negative net income, which was reported at -$21.5 million for Q2 2026, indicating ongoing financial strain that could impact investor confidence.
ACRS cerró en $6.01 el Friday, tras bajar -2.44%
Aclaris Therapeutics, Inc. (ACRS) last closed at $6.01, losing -2.44%. These facts feed the 1-day and 1-week ACRS price prediction above.
Consenso de analistas
Aclaris Therapeutics, Inc. (ACRS): 6 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Aclaris Therapeutics, Inc. (ACRS) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de ACRS, ordenadas por similitud.
Análisis de estacionalidad de ACRS
Historically the probability of a positive August return for ACRS is 66.67%. December offers the highest probability of a positive month at 100.00%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de ACRS
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $0.87 | $0.90 | $1.05 | -84.96% |
| Sep 2026 | $0.88 | $0.93 | $1.11 | -84.46% |
| Oct 2026 | $0.71 | $0.73 | $0.81 | -87.89% |
| Nov 2026 | $0.58 | $0.73 | $0.88 | -87.89% |
| Dec 2026 | $0.77 | $0.84 | $0.91 | -85.96% |
En 2026, se proyecta que Aclaris Therapeutics, Inc. (ACRS) oscile entre $0.58 y $1.11.
Previsión mensual de Aclaris Therapeutics, Inc. para 2026
En Aug de 2026, se proyecta que Aclaris Therapeutics, Inc. promedie $0.90, con un mínimo de $0.87 y un máximo de $1.05.
En Sep de 2026, se proyecta que Aclaris Therapeutics, Inc. promedie $0.93, con un mínimo de $0.88 y un máximo de $1.11.
En Oct de 2026, se proyecta que Aclaris Therapeutics, Inc. promedie $0.73, con un mínimo de $0.71 y un máximo de $0.81.
En Nov de 2026, se proyecta que Aclaris Therapeutics, Inc. promedie $0.73, con un mínimo de $0.58 y un máximo de $0.88.
En Dec de 2026, se proyecta que Aclaris Therapeutics, Inc. promedie $0.84, con un mínimo de $0.77 y un máximo de $0.91.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.